Author

W. J. Placzek

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. McGriff· 1 shared B. Shi· 1 shared C. Zang· 1 shared H. Jiang· 1 shared J. Hu· 1 shared K. Shah· 1 shared R. H. Whitaker· 1 shared T. Busby· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. McGriff

Author profile →

2 papers

Recent·Most cited

Phylogenetic analysis of the MCL1 BH3 binding groove and rBH3 sequence motifs in the p53 and INK4 protein families

W. J. Placzek, A. McGriff

The paper analyzes the conservation of the rBH3 motif in the p53 and INK4 families by examining MCL1's BH3 binding groove and constructing phylogenetic trees.

bioRxiv · Nov 2, 2022Biochemistry

Specific inhibition of DPY30 activity by ASH2L-derived peptides suppresses blood cancer cell growth

K. Shah, R. H. Whitaker, T. Busby, J. Hu, B. Shi, Z. Wang, C. Zang, W. J. Placzek, H. Jiang

The paper develops DPY30-targeting peptides that inhibit blood cancer cell growth by disrupting ASH2L binding and H3K4 methylation.

bioRxiv · Feb 19, 2019Cancer Biology